Back
Outlook Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
OTLK
Outlook Therapeutics, Inc.
Last Price:
$1.87
Seasonality Move:
13.24%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and OTLK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Outlook Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.96 | Buy |
| 20-day SMA: | 2.01 | Sell |
| 50-day SMA: | 1.68 | Buy |
| 200-day SMA: | 1.63 | Buy |
| 8-day EMA: | 1.95 | Buy |
| 20-day EMA: | 1.94 | Buy |
| 50-day EMA: | 1.77 | Buy |
| 200-day EMA: | 2.06 | Sell |
Outlook Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 53.34 | Buy |
| Chaikin Money Flow: | 5829933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.78 - 2.14) | Buy |
| Bollinger Bands (100): | (1.04 - 2.1) | Buy |
Outlook Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Outlook Therapeutics, Inc. Stock
Is Outlook Therapeutics, Inc. Stock a Buy?
-
Outlook Therapeutics, Inc. share price is 1.98 while OTLK 8-day simple moving average is 1.96, which is a Buy signal.
-
The stock price of OTLK is 1.98 while Outlook Therapeutics, Inc. 20-day SMA is 2.01, which makes it a Sell.
-
Outlook Therapeutics, Inc. 50-day simple moving average is 1.68 while OTLK share price is 1.98, making it a Buy technically.
-
OTLK stock price is 1.98 and Outlook Therapeutics, Inc. 200-day simple moving average is 1.63, creating a Buy signal.
OTLK Technical Analysis vs Fundamental Analysis
Sell
46
Outlook Therapeutics, Inc. (OTLK)
is a Sell
Is Outlook Therapeutics, Inc. a Buy or a Sell?
-
Outlook Therapeutics, Inc. stock is rated a SellThe current Outlook Therapeutics, Inc. [OTLK] share price is $1.98. The Score for OTLK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Outlook Therapeutics, Inc. Stock Info
Market Cap:
126.9M
Price in USD:
1.98
Share Volume:
5.8M
Outlook Therapeutics, Inc. 52-Week Range
52-Week High:
3.39
52-Week Low:
0.79
Sell
46
Outlook Therapeutics, Inc. (OTLK)
is a Sell
Outlook Therapeutics, Inc. Share Price Forecast
-
What is the Outlook Therapeutics, Inc. stock price today?The Outlook Therapeutics, Inc. stock price is 1.98 USD today.
-
Will OTLK stock go up or go down?Outlook Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Outlook Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Outlook Therapeutics, Inc. is overvalued.
Is Outlook Therapeutics, Inc. Stock a Buy?
-
Outlook Therapeutics, Inc. share price is 1.98 while OTLK 8-day exponential moving average is 1.95, which is a Buy signal.
-
The stock price of OTLK is 1.98 while Outlook Therapeutics, Inc. 20-day EMA is 1.94, which makes it a Buy.
-
Outlook Therapeutics, Inc. 50-day exponential moving average is 1.77 while OTLK share price is 1.98, making it a Buy technically.
-
OTLK stock price is 1.98 and Outlook Therapeutics, Inc. 200-day simple moving average is 2.06, creating a Sell signal.
Fundamental Analysis of Outlook Therapeutics, Inc.
Is Outlook Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.36 per share.
Technical Analysis of Outlook Therapeutics, Inc.
Should I short Outlook Therapeutics, Inc. stock?
-
OTLK Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Outlook Therapeutics, Inc. is a Buy
-
Outlook Therapeutics, Inc. Relative Strength Index (RSI) is 53.34, which suggest Outlook Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Outlook Therapeutics, Inc. is (1.78 - 2.14), which suggest Outlook Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Outlook Therapeutics, Inc. is (1.04 - 2.1), which suggest Outlook Therapeutics, Inc. is a Buy
* Outlook Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.